During the past decade, Universitätsklinikum Rostock Zentrum für Nervenheilkunde conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Rostock Zentrum für Nervenheilkunde" are "Alzheimer Disease" (2 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Universitätsklinikum Rostock Zentrum für Nervenheilkunde" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Rostock Zentrum für Nervenheilkunde" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (3 trials), "Placebo" (3 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Rostock Zentrum für Nervenheilkunde" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Rostock Zentrum für Nervenheilkunde". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsklinikum Rostock Zentrum für Nervenheilkunde, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Rostock Zentrum für Nervenheilkunde, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".